Goldman Sachs
GOCO

Goldman Sachs’s GoHealth GOCO Stock Holding History

Goldman Sachs’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,020
Closed -$21.2K – 6761
2026
Q1 		$21.2K Buy
14,020
+1,997
+17% +$3.82K ﹤0.01% 6360
2025
Q4 		$25.8K Buy
+12,023
New +$41.1K ﹤0.01% 6325
2025
Q3 		– Sell
-10,403
Closed -$57.7K – 6456
2025
Q2 		$57.7K Sell
10,403
-5,678
-35% -$44.9K ﹤0.01% 5894
2025
Q1 		$197K Sell
16,081
-95
-0.6% -$1.45K ﹤0.01% 5646
2024
Q4 		$217K Buy
16,176
+3,294
+26% +$37.5K ﹤0.01% 5613
2024
Q3 		$121K Buy
+12,882
New +$130K ﹤0.01% 5551
2023
Q2 		– Sell
-10,059
Closed -$164K – 5871
2023
Q1 		$164K Buy
+10,059
New +$155K ﹤0.01% 5362
2022
Q4 		– Sell
-4,914
Closed -$26K – 6105
2022
Q3 		$26K Sell
4,914
-10,939
-69% -$82.4K ﹤0.01% 5889
2022
Q2 		$142K Sell
15,853
-18,583
-54% -$216K ﹤0.01% 5751
2022
Q1 		$609K Buy
34,436
+23,524
+216% +$732K ﹤0.01% 5188
2021
Q4 		$620K Sell
10,912
-9,355
-46% -$624K ﹤0.01% 5224
2021
Q3 		$1.53M Buy
20,267
+10,681
+111% +$1.13M ﹤0.01% 4415
2021
Q2 		$1.61M Sell
9,586
-20,693
-68% -$3.62M ﹤0.01% 4390
2021
Q1 		$5.31M Buy
30,279
+18,737
+162% +$3.78M ﹤0.01% 3089
2020
Q4 		$2.37M Buy
11,542
+2,116
+22% +$393K ﹤0.01% 3608
2020
Q3 		$1.84M Buy
+9,426
New +$2.27M ﹤0.01% 3627

Other funds holding GOCO

Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $19B AUM 51.73% 1-Year Est. Return
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.5B AUM 19.48% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 26.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Goldman Sachs's GOCO Position: Q2 2026 in Review

Goldman Sachs sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 14,020 shares — an estimated $21.2K sold.

Goldman Sachs first reported a position in GOCO in Q3 2020 and held it in 16 quarters. The position peaked at $5.31M in Q1 2021. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • Goldman Sachs reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 14,020 GoHealth shares in Q2 2026, an estimated $21.2K.
  • Goldman Sachs first reported a position in GoHealth in Q3 2020 and held it in 16 quarters.
  • Goldman Sachs's GoHealth position peaked at $5.31M in Q1 2021.
  • 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.